Page last updated: 2024-08-21

quinazolines and Blood Clot

quinazolines has been researched along with Blood Clot in 41 studies

Research

Studies (41)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (12.20)	18.7374
1990's	4 (9.76)	18.2507
2000's	11 (26.83)	29.6817
2010's	14 (34.15)	24.3611
2020's	7 (17.07)	2.80

Authors

Authors	Studies
Bhavan, PS; Chang, CC; Hsia, CW; Hsieh, CY; Huang, CJ; Huang, WC; Jayakumar, T; Lin, WT; Sheu, JR; Shu, LH; Tran, OT	1
Bhavan, PS; Chung, CL; Hou, SM; Hsia, CH; Hsia, CW; Huang, WC; Jayakumar, T; Sheu, JR; Wu, MP	1
Fleischman, A; Gotlib, J; Heaney, M; Hoffman, R; Kremyanskaya, M; Kuykendall, A; Mascarenhas, J; Mesa, R; O'Connell, C; Podoltsev, N; Rippel, N; Shammo, JM; Tremblay, D; Yacoub, A; Zubizarreta, N	1
Leng, M; Li, L; Meng, Z; Peng, Y; Wan, W; Wang, J; Wang, Q; Wu, K; Yang, L; Yang, X; Ye, Y; Zou, J	1
Alvarez-Larrán, A; Ferrer-Marín, F; Santaliestra, M	1
Anaclerico, B; Andriani, A; Baldacci, E; Breccia, M; Cedrone, M; Cimino, G; Di Veroli, A; Latagliata, R; Mazzucconi, MG; Montanaro, M; Montefusco, E; Paoloni, F; Porrini, R; Rago, A; Santoro, C; Scaramucci, L; Spadea, A; Spirito, F; Villivà, N	1
Demeter, J; Dombi, P; Egyed, M; Ercsei, I; Gasztonyi, Z; Gy Korom, V; Herczeg, J; Homor, L; Illes, A; Karadi, E; Kellner, A; Simon, Z; Szerafin, L; Udvardy, M	1
Baek, S; Choi, SY; Lee, H; Na, J	1
Qian, HL; Xu, S; Zhu, LZ	1
Begna, KH; Christopher Hook, C; Elliott, MA; Gangat, N; Hanson, CA; Ketterling, RP; Pardanani, A; Patnaik, MM; Szuber, N; Tefferi, A; Vallapureddy, RR; Wolanskyj, AP	1
Cervinek, L; Dulíček, P; Kissová, J; Ovesná, P; Pavlík, T; Penka, M; Pospíšilová, D; Schwarz, J	1
Ahn, IE; Natelson, E; Rice, L	1
Balasubramaniam, K; Dragone, J; Grose-Hodge, R; Martin, P; Preston, P; Troy, S; Viswanathan, G; Zaman, AG	1
Bourkova, L; Bulikova, A; Kissova, J; Ovesna, P; Penka, M	1
Bang, SM; Kim, JW; Kim, SH; Kim, YJ; Lee, JO; Lee, JS; Lee, KW; Lim, Y	1
Brychtová, Y; Campr, V; Černá, O; Červinek, L; Cmunt, E; Doubek, M; Dulíček, P; Kissová, J; Křen, L; Maaloufová Soukupová, J; Ovesná, P; Penka, M; Schwarz, J	1
Chai-Adisaksopha, C; Garcia, D; Samuelson, B	1
Buxhofer-Ausch, V; Gastl, G; Gisslinger, B; Gisslinger, H; Ruckser, R; Schimetta, W; Schloegl, E; Sormann, S; Steurer, M	1
Demeter, J; Dombi, P; Egyed, M; Homor, L; Illés, Á; Karadi, E; Simon, Z; Udvardy, M	1
Bareford, D; Buck, G; Campbell, PJ; Erber, WN; Green, AR; Harrison, CN; Wheatley, K; Wilkins, BS; Wright, P	1
Schlag, R; Schmitz, S; Stauch, M	1
Vannucchi, AM	1
Barbui, T	2
Barbui, T; Finazzi, G; Rodeghiero, F; Ruggeri, M	1
Bareford, D; Buck, G; Campbell, PJ; East, CL; Green, AR; Grigg, AP; Harrison, CN; Reilly, JT; Revell, P; van der Walt, JD; Wheatley, K; Wilkins, BS; Woodcock, BE	1
Barbui, T; Finazzi, G	1
Abe, T; Hagiri, S; Ishii, K; Katagiri, M; Kato, E; Kobayashi, H; Kuboto, M; Masuda, N; Mitsufuji, H; Onoda, S; Ryuge, S; Takada, N; Tanaka, N; Wada, M; Yamamoto, M; Yanaihara, T; Yanase, N; Yokoba, M	1
Cacciola, E; Cacciola, RR; Cipolla, A; Di Francesco, E; Giustolisi, R	1
Kanazawa, S; Kinoshita, Y; Muramatsu, M; Nomura, S; Yamaguchi, K	1
Cacciola, E; Cacciola, RR; Di Francesco, E; Giustolisi, R; Pezzella, F; Tibullo, D	1
Ferber, RH; Parrish, SL; Vigdahl, RL	1
Barbui, T; Brière, J; Dupuy, E; Finazzi, G; Kiladjian, JJ	1
Mesa, RA; Petitt, RM; Silverstein, MN; Solberg, LA; Tefferi, A	1
Silverstein, MN; Tefferi, A	1
Storen, EC; Tefferi, A	1
Buyniski, JP; Fleming, JS	1
Fredrickson, JM; Glynn, MF; Griffiths, MV	1
Bierwagen, ME; Buyniski, JP; Cavanagh, RL; Fleming, JS	1
Hoagland, HC; McIntyre, KJ; Petitt, RM; Silverstein, MN	1
Matsumoto, M	1

Reviews

7 review(s) available for quinazolines and Blood Clot

Article	Year
Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis. Journal of thrombosis and thrombolysis, 2015, Volume: 40, Issue:4 Topics: Hemorrhage; Humans; Hydroxyurea; Quinazolines; Thrombocythemia, Essential; Thrombosis	2015
JAK2 mutation and thrombosis in the myeloproliferative neoplasms. Current hematologic malignancy reports, 2010, Volume: 5, Issue:1 Topics: Amino Acid Substitution; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Fibrinolytic Agents; Humans; Incidence; Interferon-alpha; Janus Kinase 2; Multicenter Studies as Topic; Mutation, Missense; Myeloproliferative Disorders; Phenotype; Point Mutation; Quinazolines; Thrombophilia; Thrombosis	2010
Indications for lowering platelet numbers in essential thrombocythemia. Seminars in hematology, 2003, Volume: 40, Issue:1 Suppl 1 Topics: Age Factors; Drug Therapy, Combination; Humans; Hydroxyurea; Interferon-alpha; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Risk Factors; Thrombocythemia, Essential; Thrombosis	2003
The leukemia controversy in myeloproliferative disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both? Seminars in hematology, 2004, Volume: 41, Issue:2 Suppl 3 Topics: Age Factors; Aged; Antineoplastic Agents, Alkylating; Antiviral Agents; Disease Progression; Female; Humans; Hydroxyurea; Interferon-alpha; Leukemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Polycythemia Vera; Quinazolines; Risk Factors; Thrombocythemia, Essential; Thrombosis	2004
Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers. Leukemia & lymphoma, 1996, Volume: 22 Suppl 1 Topics: Adult; Aged; Alkylating Agents; Anemia, Megaloblastic; Arrhythmias, Cardiac; Bone Marrow Diseases; Busulfan; Female; Hemorrhage; Humans; Hydroxyurea; Immunologic Factors; Incidence; Interferon-alpha; Ischemic Attack, Transient; Leukemia; Male; Middle Aged; Pipobroman; Platelet Aggregation Inhibitors; Platelet Count; Prognosis; Quinazolines; Risk Factors; Thrombocythemia, Essential; Thrombosis	1996
Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indications. Seminars in thrombosis and hemostasis, 1997, Volume: 23, Issue:4 Topics: Animals; Bone Marrow; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Hematopoiesis; Hemodynamics; Humans; Megakaryocytes; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines; Thrombocythemia, Essential; Thrombosis	1997
Treatment of polycythaemia vera and essential thrombocythaemia. Bailliere's clinical haematology, 1998, Volume: 11, Issue:4 Topics: Adult; Aged; Aspirin; Chlorambucil; Disease Progression; Female; Hemorrhage; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Middle Aged; Phlebotomy; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Prospective Studies; Quinazolines; Thrombocythemia, Essential; Thrombosis	1998

Trials

4 trial(s) available for quinazolines and Blood Clot

Article	Year
Antithrombotic properties of rafigrelide: a phase 1, open-label, non-randomised, single-sequence, crossover study. Thrombosis and haemostasis, 2014, Jul-03, Volume: 112, Issue:1 Topics: Adult; Aspirin; Blood Coagulation; Blood Platelets; Cross-Over Studies; Drug Therapy, Combination; Headache; Humans; Imidazoles; Male; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Thrombelastography; Thrombocytopenia; Thrombosis	2014
Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jun-20, Volume: 27, Issue:18 Topics: Biomarkers; Bone Marrow; Hemoglobins; Hemorrhage; Humans; Hydroxyurea; Leukocyte Count; Platelet Aggregation Inhibitors; Platelet Count; Primary Myelofibrosis; Prognosis; Prospective Studies; Quinazolines; Reticulin; Thrombocythemia, Essential; Thrombosis	2009
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. The New England journal of medicine, 2005, Jul-07, Volume: 353, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Primary Myelofibrosis; Quinazolines; Thrombocythemia, Essential; Thrombosis	2005
Effect of anagrelide on platelet coagulant function in patients with essential thrombocythemia. Acta haematologica, 2007, Volume: 118, Issue:4 Topics: Adult; Aged; Antithrombin III; Aspirin; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Hemorrhage; Humans; Hydroxyurea; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Factor 4; Prothrombin; Quinazolines; Thrombocythemia, Essential; Thrombosis	2007

Other Studies

30 other study(ies) available for quinazolines and Blood Clot

Article	Year
Rutaecarpine, an Alkaloid from International journal of molecular sciences, 2021, Oct-15, Volume: 22, Issue:20 Topics: Alkaloids; Animals; Cell Adhesion Molecules; Cells, Cultured; Evodia; Glycogen Synthase Kinase 3 beta; Humans; Indole Alkaloids; Male; Mice; Mice, Inbred ICR; Microfilament Proteins; Nucleotides, Cyclic; Phosphatidylinositol 3-Kinases; Phosphoproteins; Plant Extracts; Platelet Activation; Platelet Aggregation; Proto-Oncogene Proteins c-akt; Quinazolines; Quinolines; Signal Transduction; Thrombosis	2021
Decreased Human Platelet Activation and Mouse Pulmonary Thrombosis by Rutaecarpine and Comparison of the Relative Effectiveness with BAY11-7082: Crucial Signals of p38-NF-κB. Molecules (Basel, Switzerland), 2022, Jan-12, Volume: 27, Issue:2 Topics: Animals; Disease Models, Animal; Fibrinolytic Agents; Free Radical Scavengers; Free Radicals; Humans; I-kappa B Kinase; Imidazoles; Indole Alkaloids; Male; Mice, Inbred ICR; NF-kappa B; Nitriles; P-Selectin; p38 Mitogen-Activated Protein Kinases; Platelet Activation; Protein Kinase Inhibitors; Pulmonary Embolism; Pyridines; Quinazolines; Sulfones; Thrombosis; Transcription Factor RelA	2022
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database. Leukemia research, 2022, Volume: 119 Topics: Cytoreduction Surgical Procedures; Humans; Polycythemia Vera; Quinazolines; Thrombocythemia, Essential; Thrombocytosis; Thrombosis	2022
Effect of Evodiamine on Collagen-Induced Platelet Activation and Thrombosis. BioMed research international, 2022, Volume: 2022 Topics: Animals; Blood Platelets; Collagen; Mice; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinazolines; Thrombosis	2022
Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia. Annals of hematology, 2022, Volume: 101, Issue:11 Topics: Hemorrhage; Humans; Platelet Aggregation Inhibitors; Quinazolines; Thrombocythemia, Essential; Thrombosis	2022
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group". European journal of haematology, 2020, Volume: 105, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anemia; Disease Management; Disease Susceptibility; Drug Substitution; Female; Follow-Up Studies; Health Care Surveys; Humans; Italy; Male; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Prognosis; Quinazolines; Retreatment; Retrospective Studies; Thrombocythemia, Essential; Thrombosis; Treatment Outcome; Young Adult	2020
Anagrelide influences thrombotic risk, and prolongs progression-free and overall survival in essential thrombocythaemia vs hydroxyurea plus aspirin. European journal of haematology, 2020, Volume: 105, Issue:4 Topics: Aspirin; Drug Therapy, Combination; Health Care Surveys; Humans; Hungary; Hydroxyurea; Quinazolines; Registries; Thrombocythemia, Essential; Thrombosis; Treatment Outcome	2020
Hemorrhage and Infarction of the Conjunctiva and Orbit in Essential Thrombocythemia. The Journal of craniofacial surgery, 2017, Volume: 28, Issue:3 Topics: Aged, 80 and over; Biopsy; Conjunctiva; Eye Hemorrhage; Female; Hematologic Agents; Humans; Hydroxyurea; Orbit; Quinazolines; Thrombocythemia, Essential; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome; Visual Acuity	2017
Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus. World journal of gastroenterology, 2018, Jun-21, Volume: 24, Issue:23 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheters; Chemoembolization, Therapeutic; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Portal Vein; Quinazolines; Retrospective Studies; Survival Rate; Thiophenes; Thrombosis; Treatment Outcome	2018
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide. American journal of hematology, 2019, Volume: 94, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow; Disease Progression; Disease-Free Survival; Drug Approval; Female; Fibrosis; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Proportional Hazards Models; Quinazolines; Retrospective Studies; Severity of Illness Index; Thrombocythemia, Essential; Thrombosis; Treatment Outcome; Young Adult	2019
[The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with othe Vnitrni lekarstvi, 2013, Volume: 59, Issue:6 Topics: Adult; Aged; Czech Republic; Female; Fibrinolytic Agents; Humans; Incidence; Male; Middle Aged; Myeloproliferative Disorders; Quinazolines; Registries; Thrombocythemia, Essential; Thrombosis	2013
Successful long-term treatment of Philadelphia chromosome-negative myeloproliferative neoplasms with combination of hydroxyurea and anagrelide. Clinical lymphoma, myeloma & leukemia, 2013, Volume: 13 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hydroxyurea; Male; Middle Aged; Myeloproliferative Disorders; Philadelphia Chromosome; Polycythemia Vera; Quinazolines; Retrospective Studies; Thrombocythemia, Essential; Thrombosis	2013
Increased mean platelet volume and immature platelet fraction as potential predictors of thrombotic complications in BCR/ABL-negative myeloproliferative neoplasms. International journal of hematology, 2014, Volume: 100, Issue:5 Topics: Adult; Aged; Blood Platelets; Case-Control Studies; Female; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Male; Mean Platelet Volume; Middle Aged; Mutation; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines; Risk Factors; Thrombosis	2014
Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden. Thrombosis research, 2015, Volume: 135, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Blood Cell Count; Comorbidity; Databases, Factual; Female; Follow-Up Studies; Hemorrhage; Hemorrhagic Disorders; Humans; Hydroxyurea; Leukocyte Count; Male; Middle Aged; Phlebotomy; Platelet Aggregation Inhibitors; Polycythemia Vera; Prognosis; Quinazolines; Retrospective Studies; Risk Factors; Thrombocythemia, Essential; Thrombophilia; Thrombosis; Young Adult	2015
Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide. European journal of haematology, 2016, Volume: 96, Issue:1 Topics: Aged; Aged, 80 and over; Amino Acid Substitution; Aspirin; Female; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Male; Mutation, Missense; Philadelphia Chromosome; Platelet Count; Prospective Studies; Quinazolines; Registries; Risk Factors; Thrombocytosis; Thrombosis	2016
Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia. European journal of haematology, 2016, Volume: 97, Issue:6 Topics: Aged; Blood Platelets; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukocyte Count; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Proportional Hazards Models; Quinazolines; Registries; Risk Assessment; Thrombocythemia, Essential; Thrombosis	2016
Anagrelide reduces thrombotic risk in essential thrombocythaemia vs. hydroxyurea plus aspirin. European journal of haematology, 2017, Volume: 98, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hungary; Hydroxyurea; Male; Middle Aged; Platelet Aggregation Inhibitors; Quinazolines; Risk; Thrombocythemia, Essential; Thrombosis	2017
Anagrelide for the treatment of thrombocythaemia in daily clinical practice: a post-marketing observational survey on efficacy and safety performed in Germany. Onkologie, 2010, Volume: 33, Issue:1-2 Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Product Surveillance, Postmarketing; Quinazolines; Thrombocythemia, Essential; Thrombosis; Young Adult	2010
Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosis. Blood, 2003, May-01, Volume: 101, Issue:9 Topics: Adolescent; Adult; Anemia; Cohort Studies; Follow-Up Studies; Hemorrhage; Humans; Hydroxyurea; Incidence; Middle Aged; Quinazolines; Risk; Thrombocythemia, Essential; Thrombophilia; Thrombosis	2003
When and how to treat essential thrombocythemia. The New England journal of medicine, 2005, Jul-07, Volume: 353, Issue:1 Topics: Antineoplastic Agents; Aspirin; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Platelet Aggregation Inhibitors; Primary Myelofibrosis; Quinazolines; Risk Factors; Thrombocythemia, Essential; Thrombosis	2005
Drug interaction between gefitinib and warfarin. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:8 Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Drug Interactions; Drug Synergism; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Thrombosis; Warfarin	2005
Treatment of symptomatic patients with essential thrombocythemia: effectiveness of anagrelide. American journal of hematology, 2005, Volume: 80, Issue:1 Topics: Adult; Aged; Blood Coagulation; Female; Humans; Lipoproteins; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Factor 4; Quinazolines; Thrombocythemia, Essential; Thrombosis	2005
Acute myocardial infarction with lung cancer during treatment with gefitinib: the possibility of gefitinib-induced thrombosis. Pathophysiology of haemostasis and thrombosis, 2005, Volume: 34, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Gefitinib; Humans; Lung Neoplasms; Myocardial Infarction; Quinazolines; Thrombosis	2005
Comparison of sulfinpyrazone and BL-3459 with S - 20344, a potent new antithrombotic agent. Thrombosis research, 1981, Mar-15, Volume: 21, Issue:6 Topics: Animals; Fibrinolytic Agents; Humans; Imidazoles; Male; Oxazoles; Platelet Aggregation; Prostaglandins E; Quinazolines; Rats; Sulfinpyrazone; Thrombosis	1981
Long-term use of anagrelide in young patients with essential thrombocythemia. Blood, 2001, Feb-15, Volume: 97, Issue:4 Topics: Adolescent; Adult; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Quinazolines; Remission Induction; Retrospective Studies; Thrombocythemia, Essential; Thrombosis; Treatment Outcome	2001
A potent new inhibitor of platelet aggregation and experimental thrombosis, anagrelide (BL-4162A). Thrombosis research, 1979, Volume: 15, Issue:3-4 Topics: Adenosine Diphosphate; Animals; Carotid Arteries; Collagen; Dogs; Electricity; Fibrinolytic Agents; Haplorhini; Hemorrhage; Humans; Imidazoles; Lasers; Macaca mulatta; Platelet Aggregation; Quinazolines; Rabbits; Rats; Thrombosis	1979
Effect of a new antithrombotic agent at microvenous anastomotic sites. Archives of otolaryngology (Chicago, Ill. : 1960), 1977, Volume: 103, Issue:6 Topics: Animals; Fibrinolytic Agents; Heparin; Imidazoles; Male; Microsurgery; Quinazolines; Rabbits; Thrombosis; Veins	1977
Pharmacology of a potent, new antithrombotic agent, 6-methyl-1,2,3,5-tetrahydroimidazo[2, 1-b] quinazolin-2-one hydrochloride monohydrate. The Journal of pharmacology and experimental therapeutics, 1975, Volume: 194, Issue:2 Topics: Animals; Carotid Arteries; Dogs; Fibrinolytic Agents; Guinea Pigs; Hemodynamics; Imidazoles; In Vitro Techniques; Lasers; Muscle, Smooth; Platelet Aggregation; Quinazolines; Rabbits; Rats; Serotonin; Shock, Hemorrhagic; Shock, Septic; Thrombosis	1975
Essential thrombocythemia in young adults. Mayo Clinic proceedings, 1991, Volume: 66, Issue:2 Topics: Adolescent; Adult; Child; Epinephrine; Female; Follow-Up Studies; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Prognosis; Quinazolines; Retrospective Studies; Thrombocythemia, Essential; Thrombosis	1991
[Behavior of platelets and leukocytes on the luminal surface of small caliber prosthetic grafts]. Nihon geka hokan. Archiv fur japanische Chirurgie, 1988, Sep-01, Volume: 57, Issue:5 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Aspirin; Blood Vessel Prosthesis; Cell Adhesion; Dogs; Graft Occlusion, Vascular; Leukocytes; Microscopy, Electron, Scanning; Platelet Adhesiveness; Polytetrafluoroethylene; Quinazolines; Thrombosis	1988